EUVIMEDEUVIMED entdecken
Crossref

Efficient Conversion of Nicotinamide Mononucleotide Based on Elucidation of the Limitations in Multienzyme Cascade Reactions

Fengrui Yu, Hongwen Li, Xianglong Li, Jianping Shi, Yanbin Feng, Song Xue iD

Biotechnology Journal · 2025

DOI: 10.1002/biot.202400707 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology Journal, 2025. Verfasst von Fengrui Yu und 5 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of Bio-Intelligent Manufacturing, School of Bioengineering, Dalian University of Technology, Dalian, Liaoning, China. Hauptthemen laut MEDLINE: Nicotinamide Mononucleotide. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nicotinamide mononucleotide (NMN), a precursor of nicotinamide adenine dinucleotide (NAD), provides a direct method for maintaining NAD levels, which may alleviate aging and metabolic disorders. However, the enzymatic conversion of NMN in cascade reactions is limited by intermediate product inhibition, and quantitative insights into these limitations remain scarce. Here, an efficient multienzyme cascade system was developed by quantifying intermediate inhibition, which synthesizes NMN from D‐ribose in three tandem reactions with an Adenosine Triphosphate (ATP) regeneration system and pyrophosphatase (PPase). A critical Adenosine Diphosphate (ADP) concentration of 0.5 mM was determined, which inhibits phosphoribosyl pyrophosphate synthetase (Prs) at 0.08 µM. The incorporation of an ATP regeneration system and PPase markedly increased the NMN yield to 81.3%. The intermediate phosphoribosyl pyrophosphate (PRPP) hydrolysis rate was measured at 3 µM/min. The highly active nicotinamide phosphoribosyltransferase (Nampt) could compete with PRPP hydrolysis, thereby increasing the yield of NMN. This research facilitates large‐scale, efficient NMN manufacturing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nicotinamide MononucleotideNicotinamide PhosphoribosyltransferaseAdenosine TriphosphatePyrophosphatasesNADAdenosine DiphosphateHydrolysisPhosphoribosyl PyrophosphateEscherichia coliRibose

Stichwörter der Autor:innen

multienzyme cascade reactionnicotinamide mononucleotidenicotinamide phosphoribosyltransferasephosphoribosyl pyrophosphate

Substanzen

Nicotinamide MononucleotideNicotinamide PhosphoribosyltransferaseAdenosine TriphosphatePyrophosphatasesNADAdenosine DiphosphatePhosphoribosyl PyrophosphateRibose

Autor:innen und Institutionen

  • MOE Key Laboratory of Bio-Intelligent Manufacturing, School of Bioengineering, Dalian University of Technology, Dalian, Liaoning, China.

ORCID-Profile: Song Xue

Förderung

  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Yu, F., Li, H., Li, X., Shi, J., Feng, Y., & Xue, S. (2025). Efficient Conversion of Nicotinamide Mononucleotide Based on Elucidation of the Limitations in Multienzyme Cascade Reactions. Biotechnology Journal. https://doi.org/10.1002/biot.202400707

Vancouver

Yu F, Li H, Li X, Shi J, Feng Y, Xue S. Efficient Conversion of Nicotinamide Mononucleotide Based on Elucidation of the Limitations in Multienzyme Cascade Reactions. Biotechnology Journal. 2025. doi:10.1002/biot.202400707

BibTeX
@article{Yu2025,
  author = {Yu, Fengrui and Li, Hongwen and Li, Xianglong and Shi, Jianping and Feng, Yanbin and Xue, Song},
  title = {Efficient Conversion of Nicotinamide Mononucleotide Based on Elucidation of the Limitations in Multienzyme Cascade Reactions},
  journal = {Biotechnology Journal},
  year = {2025},
  doi = {10.1002/biot.202400707}
}
Kostenlos starten →